News Release | Investor Relations | Corporate Information

FY2025

June 5, 2025	Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income) (pdf, 149KB)
May 27, 2025	Notice of the 93rd Ordinary General Meeting of Shareholders. (pdf, 708KB)
May 14, 2025	Summary of Consolidated Financial Results for the Fiscal Year 2024. (pdf, 257KB)
May 14, 2025	Business summary FY2024. (pdf, 1,200KB)
April 21, 2025	Discovery that citrate, which keeps the body's internal environment weakly alkaline, is effective in preventing or treating peripheral neuropathy induced by anticancer drugs. (pdf, 445KB)